SMS Pharmaceuticals Limited

NSE SMSPHARMA.NS

SMS Pharmaceuticals Limited Price to Earnings Ratio (P/E) on February 06, 2025: 34.82

SMS Pharmaceuticals Limited Price to Earnings Ratio (P/E) is 34.82 on February 06, 2025, a 122.38% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

SMS Pharmaceuticals Limited 52-week high Price to Earnings Ratio (P/E) is 64.05 on September 23, 2024, which is 83.93% above the current Price to Earnings Ratio (P/E).
SMS Pharmaceuticals Limited 52-week low Price to Earnings Ratio (P/E) is -222.77 on March 18, 2024, which is -739.69% below the current Price to Earnings Ratio (P/E).
SMS Pharmaceuticals Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 10.52.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NSE: SMSPHARMA.NS

SMS Pharmaceuticals Limited

CEO	Mr. Ramesh Babu Potluri
IPO Date	Feb. 28, 2007
Location	India
Headquarters	Plot No. 72
Employees	1,197
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Plastics

Description

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.

Key trends

Past 5 years